|
Multi-Omics |
19680 |
Proteomic discovery analysis of machine learned CT emphysema subtypes in population-based studies with replication in the SPIROMICS and COPDGene studies |
Daniel E. Guzman |
|
Multi-Omics |
11776 |
Proteomic profiling of cardiometabolic phenotypes: a comparison of aptamer- and antibody-based platforms |
Daniel H Katz |
|
Multi-Omics |
15907 |
Proteomic signatures of CHIP and CHIP subtypes in Framingham Heart Study participants |
Ann Walsh |
|
Multi-Omics |
17630 |
Proteomic Signatures of Plasma Extracellular MiRNAs |
Ann Walsh |
|
Multi-Omics |
17518 |
Random Field Method for mapping molecular QTLs and discovering molecular pathways contributing to T2D risk |
Ming Li |
|
Multi-Omics |
17066 |
RNAseq and mortality |
Ann Walsh |
|
Multi-Omics |
13057 |
Serum metabolomics, clonal hematopoiesis of indeterminate potential, and risk of coronary artery disease |
Sumeet Khetarpal |
|
Multi-Omics |
17917 |
SEX-SPECIFIC DIFFERENCES IN COPD SYMPTOMS ARE DRIVEN BY SPHINGOLIPID METABOLISM |
Francesca Polverino |
|
Multi-Omics |
16704 |
The association of depressive symptoms and global stress with plasma proteins |
LaShaunta Glover |
|
Multi-Omics |
17201 |
TOPMed Proteomic Associations of Dual-Energy CT-derived Pulmonary Microvascular Blood Volume in the Community. The MESA Lung Study |
Daniel E. Guzman |
